United Kingdom · Question · Written question
UIN 29742
Astrazeneca
Introduced
6 February 2025
Last action
14 February 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
14 February 2025
Summary
To ask the Secretary of State for Science, Innovation and Technology, with reference to the oral contribution by the hon. Member for Havant of 3 February 2025, Official Report, column 552, for what reason the letter from AstraZeneca of 9 July 2025 to the
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
6 February 2025
Written question
To ask the Secretary of State for Science, Innovation and Technology, with reference to the oral contribution by the hon. Member for Havant of 3 February 2025, Official Report, column 552, for what reason the letter from AstraZeneca of 9 July 2025 to the
Source: Commons
14 February 2025
Answer
The Government has had numerous discussions with AstraZeneca about their proposed investment into Speke. There were minor delays in replying to correspondence following the election period.
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department for Science, Innovation and Technology · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-02-06/29742
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1763147
- uk · wq-1763147 · source updated 14 February 2025